📰 Synuclein Aggregation News
Synuclein Aggregation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Synuclein Aggregation. Real-time updates on events, politics, business and more.
April 10, 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”),...
April 10, 2024
MELBOURNE, Australia and SAN FRANCISCO, April 10, 2024 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...
February 20, 2024
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to...
February 20, 2024
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference – – Baseline Biomarker Data to be Presented from Ongoing ATH434-201...
February 20, 2024
– Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease to be Presented at International Conference –
November 16, 2023
MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...
November 15, 2023
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 November 16, 2023November 16, 2023 Alterity Therapeutics ...
January 10, 2023
Society for Science proudly announces the top 300 scholars in the Regeneron Science Talent Search 2021, the nation’s oldest and most prestigious science and math competition for high school seniors.